產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-DNAH1抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-DNAH1抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-DNAH1
Cat. Number:
Anti-DNAH1抗體KL-14359R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Dyneins are multisubunit, high molecular weight ATPases that interact with microtubules to generate force by converting Anti-DNAH1抗體the chemical energy of ATP into the mechanical energy of movement. Axonemal Dynein motors contain one to three non-identical heavy chains and cause a sliding of microtubules in the axonemes of cilia and flagella in a mechanism necessary for cilia to beat and propel the cell. DNAH1 (dynein heavy chain 1, axonemal), also known as heat shock regulated protein 1 or ciliary dynein heavy chain 1, is a 4,330 amino acid protein consisting of at least two heavy chains and several intermediate and light chains. Mutations in the gene encoding DNAH1 may be a cause of primary ciliary dyskinesia, also known as Kartagener Syndrome, which is characterized by chronic recurrent respiratory infections due to defective cilia action in the respiratory tract. There are three isoforms of DNAH1 that exist as a result of alternative splicing events.
Also known as:
axonemal; Axonemal beta Anti-DNAH1抗體dynein heavy chain 1; Ciliary dynein heavy chain 1; DNAH1; DNAHC1; DYH1_HUMAN; Dynein heavy chain 1; hDHC7; Heat shock regulated protein 1; Ciliary dynein heavy chain 1; HL 11; HL11; HSRF-1; XLHSRF-1.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Pig, Cow, Rabbit, .
●
Immunogen: KLH conjugated synthetic peptide derived from human DNAH1.
●
Predicted Molecular Weight: Anti-DNAH1抗體494kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-DNAH1抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-DNAH1抗體
Optimal working dilutions must be determined by the end user.
kl927Mu01 二肽基肽酶8(DPP8)多克隆抗體 Polyclonal Antibody to Dipeptidyl Peptidase 8 (DPP8)
kl933Ra01 腫瘤壞死因子配體超家族成員12(TNFSF12)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Ligand Superfamily, Member 12 (TNFSF12)
kl937Hu01 肽聚糖識(shí)別蛋白1(PGLYRP1)多克隆抗體 Polyclonal Antibody to Peptidoglycan Recognition Protein 1 (PGLYRP1)
kl937Mu01 肽聚糖識(shí)別蛋白1(PGLYRP1)多克隆抗體 Polyclonal Antibody to Peptidoglycan Recognition Protein 1 (PGLYRP1)
kl946Ra01 核受體亞家族1D組成員2(NR1D2)多克隆抗體 Polyclonal Antibody to Nuclear Receptor Subfamily 1, Group D, Member 2 (NR1D2)
kl950Hu01 孕烷X受體(PXR)多克隆抗體 Polyclonal Antibody to Pregnane X Receptor (PXR)
kl950Ra01 孕烷X受體(PXR)多克隆抗體 Polyclonal Antibody to Pregnane X Receptor (PXR)
kl960Hu01 雌**受體相關(guān)受體α(ERRα)多克隆抗體 Polyclonal Antibody to Estrogen Related Receptor Alpha (ERRa)
kl963Ra01 神經(jīng)生長(zhǎng)因子誘導(dǎo)蛋白B(NGFIB)多克隆抗體 Polyclonal Antibody to Nerve Growth Factor IB (NGFIB)
kl977Hu01 腎上腺素能受體α2C(ADRα2C)多克隆抗體 Polyclonal Antibody to Adrenergic Receptor Alpha 2C (ADRa2C)
kl977Ra01 腎上腺素能受體α2C(ADRα2C)多克隆抗體 Polyclonal Antibody to Adrenergic Receptor Alpha 2C (ADRa2C)
kl981Hu01 二甲基精氨酸二甲胺水解酶2(DDAH2)多克隆抗體 Polyclonal Antibody to Dimethylarginine Dimethylaminohydrolase 2 (DDAH2)
kl982Hu01 二甲基精氨酸二甲胺水解酶1(DDAH1)多克隆抗體 Polyclonal Antibody to Dimethylarginine Dimethylaminohydrolase 1 (DDAH1)
kl993Hu01 組織蛋白酶G(CTSG)多克隆抗體 Polyclonal Antibody to Cathepsin G (CTSG)
kl993Mu01 組織蛋白酶G(CTSG)多克隆抗體 Polyclonal Antibody to Cathepsin G (CTSG)
kl993Ra01 組織蛋白酶G(CTSG)多克隆抗體 Polyclonal Antibody to Cathepsin G (CTSG)
kl001Hu01 CREB調(diào)節(jié)轉(zhuǎn)錄輔激活因子3(CRTC3)多克隆抗體 Polyclonal Antibody to CREB Regulated Transcription Coactivator 3 (CRTC3)
kl002Hu01 CREB結(jié)合蛋白(CREBBP)多克隆抗體 Polyclonal Antibody to CREB Binding Protein (CREBBP)
